Literature DB >> 7492284

Immunosuppression augments growth of graft-adherent Staphylococcus epidermidis.

T M Bergamini1, R A Corpus, T M McCurry, J C Peyton, K R Brittian, W G Cheadle.   

Abstract

OBJECTIVE: To determine if systemic suppression of host defenses during graft implantation alters the initial adherence and subsequent growth of Staphylococcus epidermidis on vascular prostheses.
DESIGN: Dacron grafts 1 cm2 were implanted in the back subcutaneous tissue of Swiss-Webster mice (n = 247), followed by topical inoculation with 2 x 10(7), 2 x 10(5), 2 x 10(3), or 2 x 10(1) colony-forming units of S epidermidis. Half of the mice were immunosuppressed with cyclophosphamide (150 mg/kg intraperitoneally), to achieve a consistent, significant decrease in the white blood cell count and major histocompatibility complex class II (Ia) expression. Control mice received an equal volume of saline solution. Graft bacterial biofilm concentrations were determined at 1 day for adherence and within 2 weeks for bacterial growth, by using sonication and quantitative agar culture.
RESULTS: Immunosuppression did not significantly alter the initial adherence of bacteria to vascular grafts. Immunosuppressed animals that were inoculated with 2 x 10(7) and 2 x 10(5) colony-forming units of S epidermidis had significantly higher bacterial biofilm concentrations as compared with those in control animals. Graft infection persisted at 14 days in all animals, with and without immunosuppression.
CONCLUSIONS: Suppression of immune function during graft implantation augmented growth of adherent bacteria. The effect of short-term perioperative immunosuppression on late-appearing S epidermidis graft infection needs further study.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7492284     DOI: 10.1001/archsurg.1995.01430120099015

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  4 in total

1.  Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection.

Authors:  A Giacometti; O Cirioni; R Ghiselli; L Goffi; C Viticchi; F Mocchegiani; A Riva; F Orlando; V Saba; G Scalise
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

2.  Polycationic peptides as prophylactic agents against methicillin-susceptible or methicillin-resistant Staphylococcus epidermidis vascular graft infection.

Authors:  A Giacometti; O Cirioni; R Ghiselli; L Goffi; F Mocchegiani; A Riva; G Scalise; V Saba
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

3.  Real-time monitoring of bacterial infection in vivo: development of bioluminescent staphylococcal foreign-body and deep-thigh-wound mouse infection models.

Authors:  Nelly A Kuklin; Gregory D Pancari; Timothy W Tobery; Leslie Cope; Jesse Jackson; Charles Gill; Karen Overbye; Kevin P Francis; Jun Yu; Donna Montgomery; Annaliesa S Anderson; William McClements; Kathrin U Jansen
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

4.  The efficacy of the quorum sensing inhibitor FS8 and tigecycline in preventing prosthesis biofilm in an animal model of staphylococcal infection.

Authors:  Oriana Simonetti; Oscar Cirioni; Federico Mocchegiani; Ivana Cacciatore; Carmela Silvestri; Leonardo Baldassarre; Fiorenza Orlando; Pamela Castelli; Mauro Provinciali; Marco Vivarelli; Erika Fornasari; Andrea Giacometti; Annamaria Offidani
Journal:  Int J Mol Sci       Date:  2013-08-07       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.